Published in PLoS One on June 20, 2012
The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int (2013) 3.38
Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Eur Arch Otorhinolaryngol (2013) 0.88
Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease. Eur Arch Otorhinolaryngol (2015) 0.76
Optimal management of Ménière's disease. Ther Clin Risk Manag (2015) 0.76
Ryanodine-induced vasoconstriction of the gerbil spiral modiolar artery depends on the Ca(2+) sensitivity but not on Ca(2+) sparks or BK channels. BMC Physiol (2016) 0.75
Two-photon microscopy allows imaging and characterization of cochlear microvasculature in vivo. Biomed Res Int (2015) 0.75
On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res (1974) 1.78
Epidemiology of vertigo. Curr Opin Neurol (2007) 1.74
Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol (2005) 1.74
Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol (2008) 1.48
Prosper Ménière. Lancet (2005) 1.47
Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev (2001) 1.41
Computer assisted leukocyte adhesion measurement in intravital microscopy. Int J Microcirc Clin Exp (1989) 1.30
Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol (1985) 1.24
Ménière's disease. Curr Opin Neurol (2004) 1.23
Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database Syst Rev (2011) 1.16
Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg (1999) 1.12
Laser Doppler measurements of cochlear blood flow. Hear Res (1983) 1.09
Techniques for the observation and measurement of red blood cell velocity in vessels of the guinea pig cochlea. Hear Res (1987) 0.99
Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev (2006) 0.97
High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series. Eur Arch Otorhinolaryngol (2011) 0.96
Intratympanic steroids for Ménière's disease or syndrome. Cochrane Database Syst Rev (2011) 0.96
The laser Doppler: a non-invasive measure of cochlear blood flow. Acta Otolaryngol (1985) 0.93
The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol (1998) 0.91
Inner ear blood flow measured with a laser Doppler system. Arch Otolaryngol (1984) 0.91
The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res (2000) 0.90
Effects of anterior inferior cerebellar artery occlusion on cochlear blood flow--a comparison between laser-Doppler and microsphere methods. Hear Res (2001) 0.89
Polarized-light intravital microscopy for study of cochlear microcirculation. Microvasc Res (1993) 0.85
Observations of cochlear microcirculation using intravital microscopy. Acta Otolaryngol (1990) 0.85
A cationic nonselective stretch-activated channel in the Reissner's membrane of the guinea pig cochlea. Am J Physiol (1998) 0.85
A comparison of laser Doppler and intravital microscopic measures of cochlear blood flow. Otolaryngol Head Neck Surg (1989) 0.83
Measurement of cochlear blood flow: intravital fluorescence microscopy. Hear Res (1989) 0.83
Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl (2000) 0.82
Medical treatment of Menière's disease: a review of literature. Acta Otolaryngol Suppl (1997) 0.80
Surgery for Ménière's disease. Cochrane Database Syst Rev (2010) 0.80
An animal model for the analysis of cochlear blood flow [corrected] disturbance and hearing threshold in vivo. Eur Arch Otorhinolaryngol (2009) 0.80
Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther (2010) 0.80
LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: application to a pharmacokinetic study in healthy volunteers. Xenobiotica (2003) 0.79
Evaluation of a new fiber-optic pressure recording system for cardiovascular measurements in mice. Am J Physiol Heart Circ Physiol (2003) 0.78
Comparative bioavailability of betahistine tablet formulations administered in healthy subjects. Arzneimittelforschung (2010) 0.77
[Inner ear blood flow with betahistine--an animal experiment study]. Laryngorhinootologie (1994) 0.77
Menière's disease. Clin Evid (2005) 0.77
Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol (2009) 4.05
Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol (2007) 3.36
Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol (2003) 2.24
Bedside differentiation of vestibular neuritis from central "vestibular pseudoneuritis". J Neurol Neurosurg Psychiatry (2008) 2.07
Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans. Brain (2005) 1.92
Brain activation patterns during imagined stance and locomotion in functional magnetic resonance imaging. Neuroimage (2004) 1.66
A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry (2013) 1.58
Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison. Neuroimage (2009) 1.56
Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage (2007) 1.52
Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuroophthalmol (2011) 1.45
Institutional profile: integrated center for research and treatment of vertigo, balance and ocular motor disorders. Restor Neurol Neurosci (2010) 1.38
Aging of human supraspinal locomotor and postural control in fMRI. Neurobiol Aging (2010) 1.29
4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain (2007) 1.20
The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol (2010) 1.19
Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin Cancer Res (2003) 1.18
Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol (2006) 1.15
Supraspinal locomotor control in quadrupeds and humans. Prog Brain Res (2008) 1.15
Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia. Brain Pathol (2007) 1.11
4-aminopyridine and cerebellar gait: a retrospective case series. J Neurol (2012) 1.10
Long-term course of Menière's disease revisited. Acta Otolaryngol (2010) 1.10
Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke (2010) 1.09
Benign paroxysmal positioning vertigo: a long-term follow-up (6-17 years) of 125 patients. Acta Otolaryngol (2006) 1.08
Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis. Eur Neurol (2005) 1.07
General vestibular testing. Clin Neurophysiol (2005) 1.04
Structural and functional plasticity of the hippocampal formation in professional dancers and slackliners. Hippocampus (2010) 1.02
Isolated floccular infarction: impaired vestibular responses to horizontal head impulse. J Neurol (2013) 1.02
Inverse U-shaped curve for age dependency of torsional eye movement responses to galvanic vestibular stimulation. Brain (2003) 0.99
Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci (2011) 0.97
Height intolerance: an underrated threat. J Neurol (2011) 0.96
Long-term course and relapses of vestibular and balance disorders. Restor Neurol Neurosci (2010) 0.95
Spatial memory and hippocampal volume in humans with unilateral vestibular deafferentation. Hippocampus (2007) 0.95
Semicircular canal, saccular and utricular function in patients with bilateral vestibulopathy: analysis based on etiology. J Neurol (2012) 0.95
Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients. Atheroscler Suppl (2009) 0.93
Downbeat nystagmus caused by a paramedian ponto-medullary lesion. J Neurol (2009) 0.93
Dually infected (HSV-1/VZV) single neurons in human trigeminal ganglia. Ann Neurol (2003) 0.93
Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation. Cancer Biol Ther (2010) 0.92
Mind the bend: cerebral activations associated with mental imagery of walking along a curved path. Exp Brain Res (2008) 0.92
Health services utilization of patients with vertigo in primary care: a retrospective cohort study. J Neurol (2014) 0.91
Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant (2003) 0.91
4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation. J Neurol (2011) 0.91
Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. J Med Virol (2010) 0.91
Functional disturbance of the locomotor network in progressive supranuclear palsy. Neurology (2013) 0.90
Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol (2014) 0.90
Images in vascular medicine: Hypoglossal nerve palsy due to internal carotid artery dissection. Vasc Med (2010) 0.90
False-positive head-impulse test in cerebellar ataxia. Front Neurol (2012) 0.90
In vivo visualization of endolyphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol (2011) 0.89
Clinical testing of otolith function: perceptual thresholds and myogenic potentials. J Assoc Res Otolaryngol (2013) 0.89
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. Int J Cancer (2010) 0.89
Medical treatment of vestibular disorders. Expert Opin Pharmacother (2009) 0.89
Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives. Drug Resist Updat (2004) 0.89
Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol (2013) 0.89
Parallel ascending vestibular pathways: anatomical localization and functional specialization. Ann N Y Acad Sci (2009) 0.88
Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Ann N Y Acad Sci (2005) 0.88
Tropomyosin sensitization in house dust mite allergic patients. Eur Arch Otorhinolaryngol (2011) 0.87
High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma. Strahlenther Onkol (2015) 0.87
Spatial memory deficits in patients with chronic bilateral vestibular failure. Ann N Y Acad Sci (2003) 0.87
Causative factors, epidemiology, and follow-up of bilateral vestibulopathy. Ann N Y Acad Sci (2009) 0.86
Dalfampridine in patients with downbeat nystagmus--an observational study. J Neurol (2013) 0.86
The Burden and Impact of Vertigo: Findings from the REVERT Patient Registry. Front Neurol (2013) 0.86
Imagined locomotion in the blind: an fMRI study. Neuroimage (2008) 0.86
Five keys for diagnosing most vertigo, dizziness, and imbalance syndromes: an expert opinion. J Neurol (2013) 0.86
Central compensation of deviated subjective visual vertical in Wallenberg's syndrome. J Neurol Neurosurg Psychiatry (2007) 0.86
Static magnetic fields affect capillary flow of red blood cells in striated skin muscle. Microcirculation (2008) 0.86
In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière's disease. Otol Neurotol (2012) 0.86
Ocular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positioning vertigo. Acta Otolaryngol (2013) 0.86
The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia. Ann N Y Acad Sci (2009) 0.85
Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity. Neoplasia (2010) 0.85
Spatial separation of visual and vestibular processing in the human hippocampal formation. Ann N Y Acad Sci (2011) 0.85
Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study. J Neurol (2012) 0.85
Gray-matter atrophy after chronic complete unilateral vestibular deafferentation. Ann N Y Acad Sci (2009) 0.85
Suppression of eye movements improves balance. Brain (2002) 0.85
Pulsating airflow and drug delivery to paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg (2011) 0.85
Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens. J Neurovirol (2012) 0.84
Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. Otol Neurotol (2007) 0.84
Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss. Otol Neurotol (2014) 0.84
No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine (Lond) (2015) 0.84
Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients. Mult Scler (2004) 0.83
Vestibular function and quality of life in vestibular schwannoma: does size matter? Front Neurol (2011) 0.83
Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol (2012) 0.83
Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci Lett (2004) 0.83
Distortion product otoacoustic emissions for assessment of intracranial hypertension at extreme altitude? Eur J Appl Physiol (2008) 0.83
Acute hyperfibrinogenemia impairs cochlear blood flow and hearing function in guinea pigs in vivo. Int J Audiol (2012) 0.83
Cranial nerve palsies: herpes simplex virus type 1 and varizella-zoster virus latency. Ann Neurol (2002) 0.82
Porous polyethylene implants in revision rhinoplasty: chances and risks. Rhinology (2007) 0.82
Human hippocampal activation during stance and locomotion: fMRI study on healthy, blind, and vestibular-loss subjects. Ann N Y Acad Sci (2009) 0.82
Saccular function less affected than canal function in bilateral vestibulopathy. J Neurol (2008) 0.82
Static magnetic fields impair angiogenesis and growth of solid tumors in vivo. Cancer Biol Ther (2009) 0.82
Herniation of the membranous labyrinth into the horizontal semicircular canal is correlated with impaired caloric response in Ménière's disease. Otol Neurotol (2012) 0.81
A clinical test of otolith function: static ocular counterroll with passive head tilt. Neuroreport (2006) 0.81
Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols. PLoS One (2013) 0.81
The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus. Ann N Y Acad Sci (2011) 0.81
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report. Mult Scler (2012) 0.81
Unilateral vestibular failure suppresses cortical visual motion processing. Brain (2008) 0.81
The prevalence of human herpesvirus 6 in human sensory ganglia and its co-occurrence with alpha-herpesviruses. J Neurovirol (2007) 0.81
Which medication do I need to manage dizzy patients? Acta Otolaryngol (2010) 0.80
Eccentric eye and head positions in darkness induce deviation from the intended path. Exp Brain Res (2006) 0.80
Model approach to neurological variants of visuo-spatial neglect. Biol Cybern (2012) 0.80